Parameters | Control (n = 23) | Lpa group (n = 23) |
---|---|---|
Original disease distribution (n) | ||
Chronic glomerulonephritis | 14 | 16 |
Diabetic nephropathy | 5 | 5 |
Nephrotic syndrome | 0 | 1 |
Obstructive nephropathy | 1 | 1 |
Hypertension | 1 | 0 |
Lupus nephropathy | 1 | 0 |
Polycystic kidney | 1 | 0 |
Previous cardiovascular disease/events(n) | 5/1 | 5/3 |
Sex (n) | ||
Female | 11 | 7 |
Male | 12 | 16 |
Age(y) | 55.4±12.2 | 51.7±13.4 |
Weight(kg) | 61.0±12.1 | 61.8±10.4 |
BMI(kg/m2) | 22.2±2.9 | 22.2±2.3 |
Scr (μmol/L) | 665 (543,823.2) | 858 (694.2,1216.1) |
WC(cm) | 76.5±7.9 | 78.5±7.6 |
CRP(mg/L) | 5.1(1.6,8.0) | 4.8(2.7,12.1) |
ESR(ml/h) | 52.0±34.1 | 67.6±32.9 |
Hb(g/L) | 76.3±15.6 | 78.0±16.6 |
RBC(× 1012/L) | 2.66±0.54 | 2.74±0.51 |
TP(g/L) | 62.6±8.2 | 58.9±10.2 |
ALB(g/L) | 37.5±6.6 | 31.8±7.2 |
ALT(U/L) | 14.73±7.19 | 14.01±8.61 |
AST(U/L) | 19.3±1.6 | 19.15±1.35 |
TG (mmol/L) | 1.61(0.86,2.69) | 1.21(0.90,1.59) |
T-CHO(mmol/L) | 3.90±0.65 | 4.01±0.59 |
LDL (mmol/L) | 1.94(1.85,2.08) | 2.16(1.9,2.36) |
HDL (mmol/L) | 1.03(0.73,1.21) | 0.99(0.92,1.15) |
ApoA (mmol/L) | 1.13(0.97,1.2) | 1.14(1.01,1.35) |
ApoB (mmol/L) | 0.73±0.2 | 0.83±0.22 |
Ca(mmol/L) | 2.13±0.25 | 1.99±0.27 |
P(mmol/L) | 1.79±0.61 | 1.93±0.56 |
Ca×P(mmol2/L2) | 47.79±15.74 | 48.31±15.51 |
iPTH (ng/L) | 301.2(148.1373.4 | 273.2(130.4553.6) |